- Shape Memory Medical raises $10M to advance aortic clinical trials
Shape Memory Medical has secured $10 million in convertible note financing led by August Global Partners, with new investor Taiwania Capital and support from HEAL Venture Lab. The Santa Clara-based company will use the funds for patient follow-up and data collection in its AAA-SHAPE Pivotal Trial, a

- Siemens Healthineers wins $31M in ARPA-H funding to develop remote robotic stroke treatment
Siemens Healthineers has secured a federal award of up to $31.1 million over five years from ARPA-H to develop autonomous, remote endovascular robotics for treating acute ischemic stroke via mechanical thrombectomy, a procedure the company aims to eventually perform with no direct human operator inv

- Renata Medical raises $25M to advance paediatric stent system
Renata Medical has closed a $25 million Series D funding round to accelerate the global rollout and pipeline development of its paediatric stent technology. The round was led by private equity firm Archimed, with existing investors also participating. The California-based company's flagship product,

- Xeltis gains EU CE mark on positive trial data for vascular access graft
Xeltis has gained a European CE mark for aXess, with 12-month pivotal data of the vascular access graft for haemodialysis demonstrating strong and higher secondary patency versus conventional arteriovenous grafts (AVGs). Xeltis’s aXess is a bioabsorbable graft for haemodialysis that is injected unde

- EmStop initiates IDE study of novel embolic protection device
EmStop announced that it kicked off the CAPTURE-2 FDA investigational device exemption (IDE) study of its embolic protection system (EPS). CAPTURE-2 evaluates the safety and performance of the EPS, an investigational device for cerebral embolic protection designed to capture and remove debris that i





